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Introduction {#sec001}
============

The autophagy-endolysosomal pathway is an evolutionally conserved degradation system that is tightly linked to a wide variety of physiological processes \[[@pone.0234180.ref001], [@pone.0234180.ref002]\]. Three different forms of the autophagic pathways; i.e., macroautophagy, microautophagy, and chaperon-mediated autophagy are currently documented. In particular, macroautophagy (hereafter referred to as "autophagy") together with the endolysosomal pathway plays a crucial role in the removal and degradation not only of cytoplasmic long-lived as well as misfolded proteins but also of damaged or superfluous organelles through a sequential step comprising the autophagosome formation, maturation (fused with endosomes and/or lysosomes) and degradation within autolysosomes/lysosomes \[[@pone.0234180.ref001]\].

A plethora of studies has been demonstrated that dysfunction of the autophagy-endolysosomal system is associated with many pathological conditions such as cancer, inflammation and neurodegenerative diseases \[[@pone.0234180.ref002]--[@pone.0234180.ref006]\]. In order to uncover the contribution of this system to the pathogenesis, and then to develop the therapeutic treatment for such disorders, proper monitoring of the autophagy-endolysosomal activities is extremely important \[[@pone.0234180.ref007]\]. Thus far, microtubule-associated protein 1 light chain 3 (LC3), whose lipidated form (LC3-II) is highly enriched onto autophagosomal membrane during entire stages of autophagy; from the formation to maturation of autophagosomes, has reliably been used for such purposes \[[@pone.0234180.ref007], [@pone.0234180.ref008]\]. In particular, LC3 tagged with a green fluorescent protein, GFP-LC3 \[[@pone.0234180.ref009]\], has widely been utilized in not only *in vitro* culture experiments but also *in vivo* animal studies. Indeed, we and others have previously reported that GFP-LC3 can be used to monitor the autophagic status as well as disease progression in a GFP-LC3-expressing animal model of amyotrophic lateral sclerosis (ALS); i.e., human mutant SOD1-expressing transgenic mice \[[@pone.0234180.ref010], [@pone.0234180.ref011]\].

Despite of such usefulness of GFP-LC3, there are some shortcomings to monitor the flux throughout the entire autophagic system due to the reason that the fluorescence of GFP diminishes under lysosomal acidic conditions. To overcome such weaknesses, several groups have generated a series of acid-resistant and -sensitive tandem fluorescent proteins fused with LC3, such as RFP-GFP-LC3 \[[@pone.0234180.ref012]--[@pone.0234180.ref014]\], mCherry-EGFP-LC3 \[[@pone.0234180.ref015]\] and GFP-LC3-RFP-LC3ΔG \[[@pone.0234180.ref016]\], as an alternate to GFP-LC3. However, since quenching the fluorescence of GFP under the course of gradual maturation and/or acidification of intralumenal endosomes and/or autophagosomes slowly and incompletely occurs, the sensitivity for monitoring the maturation of endosomes and autophagosomes using these tandem fusion LC3 proteins might still be limited. Another type of the pH-sensitive and acid-resistant tandem probes such as mTagRFP-mWasabi-LC3 \[[@pone.0234180.ref017]\] and pHluorin-mKate2-tagged LC3 \[[@pone.0234180.ref018]\], both of which seemed to be more appropriate to monitor the maturation of autophagosomes, was also reported, but their sensitivities for monitoring the acidification of particular vesicles have yet to be thoroughly investigated.

Recently, a fluorescent variant of a protein from the stony coral *Montipora*, called Keima, has been developed \[[@pone.0234180.ref019]\], and applied to monitor the autophagy activity \[[@pone.0234180.ref020]\]. With the use of monomeric Keima-Red (mKeima-Red), which has variable excitation spectra in a pH-dependent fashion and shows proteolytic resistance in acidic compartments, the entire autophagy flux can be more efficiently monitored by a single fluorescence protein alone \[[@pone.0234180.ref020]\]. When mKeima fuses with a tandem repeat sequence of cytochrome c oxidase subunit 8 (mt-mKeima), it can also be specifically recruited to mitochondria, allowing a sensitive and selective monitoring of mitophagy with the simultaneous use of other green emitting fluorophores in cells \[[@pone.0234180.ref020]\]. Thus, if mKeima could be properly targeted to the membrane of autophagosomes as well as endocytic vesicles by fusing with selectively localized molecules such as LC3, a more selective and sensitive monitoring of the vesicular maturation and acidification would become possible. Furthermore, like GFP-LC3, in order to measure the autophagic-flux in tissues and/or cells by Western blotting with the use of appropriate antibodies \[[@pone.0234180.ref010]\], mKeima-fused LC3 could be utilized as an "autophagomometer" \[[@pone.0234180.ref008]\] much easier than endogenous LC3.

In this study, by exploiting merits of mKeima and LC3 combined, we newly developed a single fluorescent protein-based and pH-sensitive probe, mKeima-LC3B, as a novel analytical tool for the autophagy-endolysosomal system. We generated transgenic (tg) mice that were expressing mKeima-LC3B. To assess their usefulness, we characterized biochemical as well as histological phenotypes of mKeima-LC3B-tg mice under stressed conditions; i.e., starvation or neurodegeneration *in vivo*. Further, we investigated cellular responses to the starvation using mouse embryonic fibroblasts (MEFs) derived from these animals *in vitro*.

Materials and methods {#sec002}
=====================

Plasmid construction {#sec003}
--------------------

We generated pCAG_mKeima_LC3B plasmid to express mKeima fused to human MAP1LC3B (LC3B) under control of the chicken β-actin (CAG) promoter in mammalian cells. The mKeima and LC3B sequences were amplified from pmKeima-S1 (MBL) and pEGFP-LC3B \[[@pone.0234180.ref021]\] by PCR using primers with site-specific restriction sites, respectively (mKeima: XhoI-AgeI-kozac-mKeima_F; `5’-gatctcgagaccggtccaccatggtgagtgtgatcgcta-3’` and PacI-mKeima_R; `5’-gatcttaattaaaccgagcaaagagtggcgtg-3’`, LC3B: PacI-LC3B_F; `5’-gatcttaattaatatgccgtcggagaagacct-3’` and SmaI-BsiWI-LC3B_R; `5’-gatcccgggcgtacgttacactgacaatttcatcccga-3’`). These amplicons were digested with proper restriction enzymes, ligated and cloned into the unique *Age*I-*Bsr*GI restriction sites of pAMF plasmid that contained \[CAG_AgeI_EGFP_BsrGI_polyA\] cassette \[[@pone.0234180.ref022]\]. Plasmid DNA for pCAG_mKeima-Red_LC3B extracted from transformed bacteria using NucleoBond Xtra Midi kit (TaKaRa) was further digested with *Not*I. Resulting *Not*I-restricted insert DNA (CAG_mKeima_LC3B_polyA) ([S1 Fig](#pone.0234180.s001){ref-type="supplementary-material"}) was purified by NucleoSpin Gel and PCR Clean-Up (TaKaRa) and subjected to microinjection.

Animals {#sec004}
-------

C57BL/6J (B6), BDF1, ICR and MCH(ICR) mice were purchased from CLEA Japan. We used two previously-established tg mice carrying the H46R mutation in the human *SOD1* gene \[SOD1^H46R^; a mouse model of amyotrophic lateral sclerosis (ALS)\] \[[@pone.0234180.ref010], [@pone.0234180.ref021], [@pone.0234180.ref023]\] and those carrying the GFP-fused human-*MAP1LC3B* cDNA (GFP-LC3) \[[@pone.0234180.ref009]\]. SOD1^H46R^-tg and GFP-LC3-tg mice were backcrossed to B6 mice for more than 10 generations and maintained as B6 congenic lines. Mice were housed at an ambient temperature of 23 ± 2˚C and humidity of 55 ± 15% with a 12 h light-dark cycle. Food and water were fed *ad libitum* unless otherwise noted. All animal experimental procedures were carried out in accord with the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and reviewed and approved by The Institutional Animal Care and Use Committee at Tokai University (Permitted \#; 181033).

Generation of mKeima-LC3B-expressing transgenic mice {#sec005}
----------------------------------------------------

To induce superovulation, we intraperitoneally injected each donor female B6 mouse (8--9 weeks of age) with 5 IU pregnant mare serum gonadotropin (PMSG) (Sankyo Yell), and female BDF1 mouse (8--12 weeks of age) with 7.5 IU PMSG. After 48 h, 5 IU human chorionic gonadotropin (hCG) (Sankyo Yell) was further injected intraperitoneally into each donor mouse. Oocytes that were recovered from superovulated female B6 and BDF1 mice were subjected to *in vitro* fertilization (IVF) with sperms obtained from B6 and BDF1 male mice (10 weeks of age), respectively. To create tg animals, we microinjected *Not*I-restricted insert DNA (CAG_mKeima_LC3B_polyA) into 428 B6-derived and 813 BDF1-derived fertilized eggs. Among them, 369 B6-derived and 511 BDF1-derived eggs were transplanted into the oviduct of pseudopregnant recipient ICR and MCH(ICR) mice, respectively.

To confirm the presence of transgene in the genome, we designed two sets of primer pair for PCR; Keima_LC3 fused gene (338 bp): Keima_F1; `5’-tctttgcacgagatggaatg-3’` and LC3B_R1; `5’-tatcaccgggattttggttg-3’`, and CAG promoter (239 bp): CAG_F2; `5’-ccgctcgacattgattattga-3’` and CAG_R2; `5’-tgccaagtgggcagtttac-3’` ([S1 Fig](#pone.0234180.s001){ref-type="supplementary-material"}). Genomic DNA was extracted from ear tissue of mice. Standard reaction mixture for ExTaq (TaKaRa) was used for amplification. Thermal conditions used were as follows; 95˚C 5 min denaturation followed by 30 cycles of \[98˚C/10 s, 56˚C/30 s, 68˚C/3 min\]. PCR products were analyzed by agarose-gel electrophoresis. B6 and BDF1-derived mKeima-LC3B-tg mice were maintained as B6 background and were backcrossed to B6 mice for 4--5 generations, respectively.

Copy number estimation {#sec006}
----------------------

Copy numbers of the transgene in tg mice were determined by quantitative PCR. Genomic DNA of each tg mouse was obtained from tail tissues by the phenol-chloroform extraction. Quantitative PCR was performed by FastSYBR Green MasterMix by 7500 Fast Real-time PCR system (LifeTec) using following primers; for the mKeima gene: Keima_F; `5’-catctgttgagcagtgaaatag-3’` and Keima_R; `5’-cgctgcttgaaggtcttctc-3’`, for the PGK gene as a control: PGK_F; `5’-caggactaaagatgcgtggat-3’` and PGK_R; `5’-acctgcaagcgctacactt-3’`. Real-time PCR was performed with thermal conditions as follows; 95˚C/2 min denaturation followed by 40 cycles of \[95˚C/3 s, 60˚C/30 s\]. Copy numbers of transgene were calculated by double delta Ct analysis compared with mKeima and PGK.

Starvation *in vivo* {#sec007}
--------------------

To study the effects of starvation *in vivo*, mice were deprived of food for 24 or 48 h. These mice were allowed to freely access drinking water.

Generation of mKeima-LC3B-expressing ALS mouse model {#sec008}
----------------------------------------------------

We generated mKeima-LC3B-expressing SOD1^H46R^ (mKeima-LC3B;SOD1^H46R^) mice by crossing male SOD1^H46R^-tg mice with female mKeima-LC3B-tg mice. The offsprings were genotyped by PCR using genomic DNA extracted from ear tissues. Primers for the SOD1 transgene were as previously described \[[@pone.0234180.ref024]\].

Antibodies {#sec009}
----------

Antibodies used for western blot analysis were as follows; primary antibodies included guinea-pig anti-human SQSTM1 (1:3000, PROGEN), rabbit anti-human LC3 (1:5000, MBL), rabbit anti-GAPDH (1:5000, Sigma-Aldrich) and mouse monoclonal anti-β-actin (1:10000, Sigma-Aldrich) antibodies. Secondary antibodies included horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (1:5000, GE Healthcare bioscience), HRP-conjugated anti-mouse IgG (1:5000, GE Healthcare bioscience) and HRP-conjugated anti-guinea-pig IgG (1:3000, SantaCruz) antibodies.

Antibodies used for immunohistochemistry were as follows; primary antibodies included rabbit anti-human LC3 (1:1000, MBL), mouse monoclonal anti-mKeima (1:1000, DAKO), isotype control mouse IgG2a (1:100, DAKO) and isotype control rabbit IgG (1:100, DAKO) antibodies. Secondary antibodies included N-Histofine® Simple Stain Mouse MAX PO (Nichirei) and EnVision+ System-HRP Labelled Polymer anti-mouse antibody (DAKO).

Western blot analysis {#sec010}
---------------------

Western blot analysis was performed as previously described \[[@pone.0234180.ref021]\] with minor modifications. Briefly, mouse tissues were homogenized in Lysis buffer \[50 mM Tris-HCl (pH7.5), 150 mM NaCl, 0.1% (w/v) SDS, 0.5% (w/v) deoxycholic acid, 1% (w/v) Triton X-100, Complete Protease Inhibitor Cocktail (Roche)\] using Shake Master NEO (Bio Medical Science Inc.). MEFs cultured in 3.5 cm culture dish were washed with phosphate buffered saline (PBS), and then lysed with Lysis buffer. After centrifugation at 12,000 × *g* for 5 min, supernatant was collected. Protein concentration of these samples was determined by DC protein assay kit (Bio-Rad Laboratories). Equal amount of protein was separated on SDS-polyacrylamide gels, and then transferred onto polyvinylidene difluoride membrane (Millipore). Membranes were blocked with 5% (w/v) skimmed milk diluted in TBST \[25 mM Tris-HCl (pH7.5), 150 mM NaCl, 0.1% (w/v) Tween-20\] for 1 h at 37˚C, and subsequently incubated with primary antibody diluted in blocking solution overnight at 4˚C. After washing with TBST, membranes were incubated with HRP-conjugated secondary antibody. Immunoreactivities of primary antibodies were visualized with Immobilon-Western Chemiluminescent HRP Substrate (Millipore) and analyzed using Ez-Capture Analyzer (ATTO). Signal intensities were quantified using CS analyzer ver 3.0 (ATTO).

Histochemistry and immunohistochemistry {#sec011}
---------------------------------------

Mice were anesthetized with 4% isoflurane by inhalation, and transcardially perfused with 4% paraformaldehyde/phosphate buffer (PFA/PB) (Muto Chemical). Tissues were removed and post-fixed for 48 h in 4% PFA/PB, followed by paraffin embedding. Paraffin sections were sliced on microtome at a thickness of 4--5 μm. For immunohistochemistry, tissue sections were deparaffinized and hydrated. Sections were incubated in Target Retrieval Solution (pH6.0) (DAKO) and heated at 120˚C for 5 min. After cooling at room temperature (RT), sections were treated with 3% H~2~O~2~ solution to inactivate endogenous peroxidase activities. For anti-mKeima antibody, sections were blocked by the treatment with PBS (pH 7.2) containing 5% normal goat serum (NGS) for 30 min at RT, followed by incubation with primary antibody in PBS for 1 h at RT. Sections were washed with PBS for 15 min and incubated with secondary antibody for 1 h. After washing with PBS for 15 min, sections were stained with 3,3\'-diaminobenzidine (DAB). For anti-LC3 antibody, sections were blocked by the treatment with TBST containing 0.05% Tween 20/5% NGS for 30 min at RT, followed by incubation with primary antibody in Antibody Diluent (DAKO) for 1 h at RT. Sections were washed with TBST for 15 min and incubated with secondary antibody for 1 h. After washing with TBST for 15 min, sections were stained with DAB. To determine specificity of immunostaining, serial sections were similarly processed except that primary antibody was omitted. Sections were counterstained with hematoxylin. Images were observed and captured by fluorescence microscope BX63 equipped with DP73 camera (Olympus).

Preparation of mouse embryonic fibroblasts and cell culture {#sec012}
-----------------------------------------------------------

Primary MEFs were established form embryos that were obtained from wild-type, mKeima-LC3B-tg and GFP-LC3-tg mice at 13.5 days post coitus. Embryos were soaked into sterile PBS and dissected, and their visible organs were removed. Remaining skin tissues were further digested and sheared by pipetting in 1 ml of Trypsin-EDTA solution (0.5 g porcine trypsin and 0.2 g EDTA-4Na/L Hanks' Balanced Salt Solution with phenol red) (Sigma-Aldrich). After incubation for 15 min at 37˚C, tissues were treated in Dulbecco\'s Modified Eagle Medium (DMEM) (Nacalai tesque) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Biowest), 100 U/ml penicillin and 100 μg/ml streptomycin (Sigma-Aldrich). Dissociated cells were seeded onto a 60 mm cultural dish at an appropriate cell density and cultured in the same culture medium in 5% CO~2~ atmosphere at 37˚C. Adherent cells as MEFs were used.

Nutrient starvation *in vitro* {#sec013}
------------------------------

For starvation, MEFs established from wild-type, mKeima-LC3B-tg and GFP-LC3-tg embryos were treated with EBSS (116.4 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl~2~, 0.8 mM MgSO~4~⋅7H~2~O, 1.0 mM NaH~2~PO~4~⋅2H~2~O, 26.2 mM NaHCO~3~, 5.6 mM Glucose). To monitor the autophagic flux, lysosomal degradation was inhibited by addition of 50 μM chloroquine (CQ), a lysosomotropic agent that inhibits the lysosomal proteases, to the medium.

Flow-cytometry {#sec014}
--------------

For data acquisition, we used a LSRFortessa flow cytometer (Becton Dickinson). Signals were measured using two parameters; emission filter 670/30nm (Qdot 655 filter) excited by violet laser (405 nm) and 610/20nm (PE-Tx-Red filter) by yellow-green laser (561 nm). All data were analyzed using FlowJo software (Becton Dickinson). MEFs were washed with PBS(-), treated with trypsin, and collected to a 1.5-ml tube (Sumitomo Bakelite). After centrifugation, cells were suspended with DMEM in the absence or presence of 50 μM CQ and transferred to 5mL Round Bottom Polystyrene Tube (CORNING), followed by recording data. To obtain data from MEFs under starved conditions, cultured cells in DMEM were washed with PBS(-) and trypsinized. After centrifugation, medium was replaced with EBSS, and capturing and processing of data were immediately (in less than 1 min) started. Four quadrants (Q1-Q4) were assigned based on the distribution of background signals observed in wild-type MEFs, in which Q4 contained the maximum number of cells within its minimum area.

Fluorescence imaging {#sec015}
--------------------

To examine the pH sensitivity of mKeima, MEFs expressing mKeima-LC3B were fixed with 4% PFA in PBS (-) (pH 7.5) for 15 min, followed by washing three times with PBS (-) at RT. After capturing the images for mKeima as a basal control, fixed cells were buffered at pH 4.0 (50 mM acetate buffer), pH 5.0 (50 mM acetate buffer), pH 6.0 (50 mM phosphate buffer), pH 7.0 (50 mM MOPS buffer), pH 8.0 (50 mM MOPS buffer) or pH 9.0 (50 mM bicine buffer). Then, fluorescent signals were detected. Fixed MEFs treated with EBSS (pH 7.4--7.6) were also observed. All images were captured and analyzed by ZEISS LSM880 laser scanning confocal microscope (Carl Zeiss).

Live-cell imaging {#sec016}
-----------------

For live-cell imaging of LC3-positive vesicular compartments in wild-type and mKeima-LC3B-tg derived MEFs, we used ZEISS LSM880 laser scanning confocal microscope equipped with a 40 x C-Apochromat water-immersion objective lens, a multi-argon laser (458, 488, and 514 nm), a DPSS laser (561 nm) and a Diode laser (405 nm) (Carl Zeiss). Images for mKeima and LysoTracker blue DND-22 (Thermo) were obtained at emission wavelengths of 616--696 nm and 406--501 nm, respectively. Images were also obtained using a 100 x Plan Apochromat (1.46 NA) oil objective on the Airyscan array detector and processed in conjunction with the Airyscan processing toolbox in the ZEN software (Carl Zeiss). Microscope incubation system was used to maintain constant environmental conditions inside the observation chamber, which was set at 37˚C by injecting heated and humidified air containing 5% CO~2~. To observe the changes in fluorescent signals for mKeima-LC3B, we repeatedly replaced culture media from DMEM to EBSS, and from EBSS to DMEM. We also measured the signals under transitional conditions from DMEM to DMEM+CQ (50 μM), DMEM to EBSS+CQ, EBSS to DMEM+CQ, EBSS to EBSS+CQ, DMEM+CQ to DMEM, DMEM+CQ to EBSS and DMEM+CQ to EBSS+CQ. Ratio (561 nm/458 nm) images of mKeima were created by ZEN software.

High-content analysis {#sec017}
---------------------

For live-cell time-lapse analysis, MEFs were cultured in a 96-well plate using live-cell chamber of a Cellomics Arrayscan VTI (Thermo) at 10 × magnification using Target Activation Bioapplication. During image capturing, culture plate was placed in an incubation chamber to maintain appropriate environmental conditions (37˚C, 5% CO~2~). Images for mKeima was obtained from fluorescent data by using these two excitation wavelengths (485 nm and 549 nm) and emission at \> 590 nm. Ratio of signal intensity (549 nm/485 nm) was used as an index of the autophagic activity.

Statistical analysis {#sec018}
--------------------

Data in this study were presented as mean ± standard deviation (S.D.) or standard error of means (S.E.M.). Statistical analyses were conducted using PRISM 8 (GraphPad). Statistical significance was evaluated by ANOVA (analysis of variance) followed by Bonferroni's multiple comparison test between groups. We considered *p*-values \< 0.05 to be statistically significance.

Results {#sec019}
=======

Generation of mKeima-LC3B-expressing transgenic mice {#sec020}
----------------------------------------------------

We microinjected *Not*I-restricted insert DNA (CAG_mKeima_LC3B_polyA) into B6-derived fertilized eggs. These eggs were transplanted into the oviduct of recipient ICR mice. As a result, a total of 60 pups was obtained. Among them, 4 mice (F~0~) were confirmed to carry the transgene in their genome. From these F~0~ mice, 3 independent lines were successfully established ([Table 1](#pone.0234180.t001){ref-type="table"}). Copy numbers of transgene in KLC3_35_105, KLC3_35_106 and KLC3_44 lines were estimated to be 80--100, 80--100 and 8 copies, respectively. To confirm the expression of protein, we next performed western blot analysis of extracts from a variety of tissues. As a control, we also used GFP-LC3-tg mice \[[@pone.0234180.ref009], [@pone.0234180.ref010]\]. Although GFP-LC3 fusion protein was ubiquitously and highly expressed in GFP-LC3-tg, mKeima-LC3B was rather preferentially expressed in the central nervous system (CNS), hearts and muscles, but not in other peripheral tissues of mKeima-LC3B-tg mice, with highest in KLC3_44 line ([Fig 1A](#pone.0234180.g001){ref-type="fig"}).

![Tissue distribution of mKeima-LC3B fusion protein in mKeima-LC3B transgenic mice.\
(A) Western blot analysis of transgene-derived proteins (GFP-LC3 and mKeima-LC3B) and endogenous LC3 in wild-type (B6), GFP-LC3 transgenic (GFP-LC3) and 3 KLC3 lines of mKeima-LC3B transgenic \[44 (hemi; hemizygote), 35_105 and 35_106\] (see [Table 1](#pone.0234180.t001){ref-type="table"}) mice. (B) Western blot analysis of mKeima-LC3B and endogenous LC3 in wild-type (B6), a KLC3 line of mKeima-LC3B transgenic \[44 (homo; homozygote)\], and 2 BDKLC3 lines of mKeima-LC3B transgenic (10--4 and 17--1) (see [Table 1](#pone.0234180.t001){ref-type="table"}) mice. Tissue samples analyzed are as follows: cerebral cortex (cerebrum), midbrain + medulla + pons (MMP), spinal cord, cerebellum, heart, gastrocnemius (muscle), liver, ling, spleen, and kidney. Twenty μg of total proteins from each tissue was subjected to SDS-PAGE and analyzed by immunoblotting using anti-LC3 antibody. GAPDH was used for a loading control. Positions of mKeima-LC3B and endogenous LC3 are indicated. White and gray arrowheads shown on the right indicate a possible truncated mKeima-LC3B (indicated as mKeima-LC3') and non-specific bands, respectively. Size-markers are shown on the left.](pone.0234180.g001){#pone.0234180.g001}

To obtain mouse lines that ubiquitously expressed mKeima-LC3B, we further injected the same DNA construct to BDF1-derived fertilized eggs, followed by transplantation into the oviduct of recipient MCH(ICR) mice. As a result, a total of 115 pups was obtained. Among them, 20 mice (F~0~) were confirmed to carry the transgene. Two out of 6 lines, which expressed mKeima-LC3B in tail tissues, were further subjected to copy number analysis, revealing that BDKLC3_10--4 and BDKLC3_17--1 lines carried 6 and 12 copies of the transgene, respectively ([Table 1](#pone.0234180.t001){ref-type="table"}). Next, we analyzed tissue distribution of mKeima-LC3B in these lines. Although BDKLC3_10--4 line showed a similar expression pattern as did KLC3_44, BDKLC3_17--1 line was confirmed to be ubiquitously expressed the mKeima-LC3B fusion protein ([Fig 1B](#pone.0234180.g001){ref-type="fig"}).

10.1371/journal.pone.0234180.t001

###### Summarized results of integrated copy number of transgene and the levels of protein expression in mKeima-LC3B transgenic lines.

![](pone.0234180.t001){#pone.0234180.t001g}

  Strain   Line               Copy numbers   Protein expression [\#](#t001fn001){ref-type="table-fn"}   Selected line
  -------- ------------------ -------------- ---------------------------------------------------------- -----------------------------------------
  B6       KLC3_35_105        80\~100        n.d.                                                       
           KLC3_35_106        80\~100        n.d.                                                       
           **KLC4_44**        **\~8**        **1.00**                                                   [\*\*](#t001fn003){ref-type="table-fn"}
  BDF1     BDKLC3_7--5        n.d.           4.80                                                       
           BDKLC3_9--1        n.d.           1.40                                                       
           **BDKLC3_10--4**   **\~6**        **2.09**                                                   [\*\*](#t001fn003){ref-type="table-fn"}
           BDKLC3_11--2       n.d.           0.56                                                       
           BDKLC3_13--2       n.d.           0.66                                                       
           **BDKLC3_17--1**   **\~12**       **2.58**                                                   [\*\*](#t001fn003){ref-type="table-fn"}

\# Relative values to mKeima-LC3B expression in tail tissue of KLC3_44 mouse.

n.d., not determined.

\*\*, Selected line: Transgenic mouse lines used for further analyses in this study.

Effects of starvation on mKeima-LC3B *in vivo* {#sec021}
----------------------------------------------

To study the effects of starvation *in vivo*, 2 lines of mKeima-LC3B-tg mice (KLC3_44 and BDKLC3_17--1) were subjected to food-restriction study. After deprivation of food for 24 or 48 h, tissue samples were prepared from each mouse and analyzed the expression of mKeima-LC3B and endogenous LC3 using anti-LC3 antibody. By western blot analysis, no visible lipidated-form of LC3 (LC3-II) for mKeima-LC3B was observed not only in the CNS but also in heart and muscles, even though strong bands representing mKeima-LC3B-I were evident. Nonetheless, it is noted that increased level of endogenous LC3-II was observed in muscles after 48 h of starvation, indicating that autophagy is upregulated, at least, in skeletal muscles in response to food deprivation ([Fig 2](#pone.0234180.g002){ref-type="fig"}).

![Western blot analysis of LC3 in tissues from mKeima-LC3B transgenic mice under starvation conditions *in vivo*.\
Two lines of mKeima-LC3B transgenic mouse (KLC3_44 and BDKLC3_17--1) were subjected to food-restriction study. Mice were fed *ad libitum* or deprived of food for either 24 or 48 h. Tissue samples analyzed are as follows: cerebral cortex (cerebrum), midbrain + medulla + pons (MMP), spinal cord, cerebellum, heart and gastrocnemius (muscle). Protein extract from whole body of a founder stillborn mouse (KLC3_56D) was also used (control). Five μg of total proteins from each tissue was subjected to SDS-PAGE and analyzed by immunoblotting using anti-LC3 antibody. Positions of mKeima-LC3B and endogenous LC3-I and LC3-II are indicated. White and gray arrowheads shown on the right indicate a possible truncated mKeima-LC3B (indicated as mKeima-LC3') and non-specific bands, respectively. Size-markers are shown on the left.](pone.0234180.g002){#pone.0234180.g002}

To further clarify autophagic response to starvation *in vivo*, we conducted immuno-histochemical analysis using either anti-LC3 or anti-mKeima antibody. Previously, it has been reported that food deprivation induces autophagy in the Purkinje cells and cortical neurons, \[[@pone.0234180.ref025]\]. However, there are no such discernable evidences in mKeima-LC3B-tg mice ([S2A--S2D Fig](#pone.0234180.s002){ref-type="supplementary-material"}). Instead, signals representing both endogenous LC3 and mKeima-LC3B were significantly increased in motor neurons of the spinal cord ([Fig 3A](#pone.0234180.g003){ref-type="fig"} and [S2E Fig](#pone.0234180.s002){ref-type="supplementary-material"}), indicating that motor neurons were highly responsive neurons to food deprivation *in vivo*. Regarding peripheral tissues, although there were no visible increased signals in the heart ([Fig 3B and 3C](#pone.0234180.g003){ref-type="fig"}), dot-like structures appeared in skeletal muscle ([Fig 3D](#pone.0234180.g003){ref-type="fig"}), which was consistent with the previous report \[[@pone.0234180.ref009]\].

![Immunohistochemical analysis of LC3 in tissues from wild-type and mKeima-LC3B transgenic mice under starvation conditions *in vivo*.\
(A) Lumbar spinal cord (L4-L5), (B and C) cardiac muscles and (D) skeletal muscle (gastrocnemius), which were prepared from mKeima-LC3B transgenic (tg) mice under either fed (control) or starved (48 h) conditions, were fixed and immunostained with anti-LC3 (α-LC3) or anti-mKeima (α-mKeima) antibody. Mouse lines used in this analysis were (A) BDKLC3_17--1, (B) KLC3_44, (C) BDKLC3_17--1, and (D) BDKLC3_17--1. Scale bars indicate (A, a-h) 200 μm, (A, a'-h') 100 μm, (B, a-h) 200 μm, (C, a-h) 100 μm and (D, a-h) 100 μm.](pone.0234180.g003){#pone.0234180.g003}

Effects of mutant SOD1 overexpression on mKeima-LC3B *in vivo* {#sec022}
--------------------------------------------------------------

We have previously shown that in double-tg SOD1^H46R^;GFP-LC3 mice, level of a lipidated-form of GFP-LC3; i.e., GFP-LC3-II is significantly increased in the spinal cord as disease progresses \[[@pone.0234180.ref010]\], implying that GFP-LC3 is an excellent molecular marker to monitor the autophagy-endolysosomal system in the CNS *in vivo*. To clarify whether mKeima-LC3B would become an alternative and utilizable maker, we generated double-tg SOD1^H46R^;mKeima-LC3B (KLC3_44) mice and analyzed mKeima-LC3B, endogenous LC3 and SQSTM1 in the brain and spinal cord from pre-symptomatic as well as end-stage double-tg mice. Unexpectedly, levels of a lipidated form of mKeima-LC3B (mKeima-LC3-II) were not changed by overexpression of mutant SOD1 despite of their advanced disease phenotypes ([Fig 4A, 4D and 4E](#pone.0234180.g004){ref-type="fig"}). By contrast, ratio of endogenous LC3-II/LC3-1, as a marker of autophagosome formation, of the same double-tg mice at end stage was significantly increased ([Fig 4B, 4F and 4G](#pone.0234180.g004){ref-type="fig"}). These results indicate that mKeima-LC3B does not properly convert to the lipidated form *in vivo* even though autophagy itself is dysregulated in the CNS, which is in stark contrast to GFP-LC3 \[[@pone.0234180.ref010]\]. It was also noted that SQSTM1 tended to be accumulated in the CNS of mKeima-LC3B-tg mice, suggesting that overexpression of mKeima-LC3B alone induced proteostatic stress *in vivo* ([Fig 4C, 4H and 4I](#pone.0234180.g004){ref-type="fig"}). Indeed, immunohistochemical analysis revealed that mKeima-LC3B-positive aggregates were progressively accumulated in the spinal cord of SOD1^H46R^;mKeima-LC3B mice ([Fig 5](#pone.0234180.g005){ref-type="fig"}), suggestive of an aggregate-prone nature of long-term overexpressed mKeima-LC3B molecules. These data demonstrate that mKeima-fused LC3 may not be an appropriate means to monitor the autophagy-endolysosomal system under stressed conditions *in vivo*.

![Effects of mutant SOD1 overexpression on autophagy-related proteins *in vivo*.\
(A-C) Western blot analysis of mKeima-LC3B, endogenous LC3 and SQSTM1 in double transgenic \[SOD1^H46R^;mKeima (KLC3_44)\] and a single mKeima-LC3B transgenic (mKeima) mice (KLC3_44). Three pre-symptomatic mice (Pre-smpt.; 13--23 weeks of age) and three end-stage mice (24--26 weeks of age) and their age-matched mKeima-LC3B transgenic mice were used. Ten μg of total proteins from each tissue \[MMP (midbrain + medulla + pons) and spinal cord\] was subjected to SDS-PAGE and analyzed by immunoblotting using anti-LC3 and anti-SQSTM1 (p62) antibodies. Western blots for (A) mKeima-LC3B, (B) endogenous LC3 and (C) SQSTM1 are shown. White arrowhead shown on the right of panel (A) indicates a possible truncated mKeima-LC3B (indicated as mKeima-LC3'). GAPDH was used for a loading control. Positions of size-markers are shown on the left. (D-I) Quantification of signal intensities in western blots. Ratios (in arbitrary unit; AU) of (D) mKeima-LC3-II/mKeima-LC3-I/GAPDH in MMP, (E) mKeima-LC3-II/mKeima-LC3-I/GAPDH in the spinal cord, (F) endogenous LC3-II/LC3I/GAPDH in MMP, (G) endogenous LC3-II/LC3I/GAPDH in the spinal cord, (H) SQSTM1/GAPDH in MMP and (I) SQSTM1/GAPDH in the spinal cord are shown. Values are expressed as mean ± (S.D.). Individual data points are also shown. Statistical significance was evaluated by one-way ANOVA with Bonferroni's post hoc test; \**p* \< 0.05, \*\**p* \< 0.01.](pone.0234180.g004){#pone.0234180.g004}

![Immunohistochemical analysis of LC3 in double transgenic mice expressing mutant SOD1 and mKeima-LC3B.\
Lumbar spinal cord (L4-L5) tissues, which was prepared from (A, a, B, and b) two pre-symptomatic and (C, c, D and d) two end-stage double transgenic mice \[SOD1^H46R^;mKeima (KLC3_44)\] expressing both mutant SOD1 (SOD1^H46R^) and mKeima-LC3B, were immunostained with anti-LC3 antibody. Scale bars indicate (A-D) 200 μm and (a-d) 100 μm.](pone.0234180.g005){#pone.0234180.g005}

Effects of starvation on mKeima-LC3B *in vitro* {#sec023}
-----------------------------------------------

Next, we investigated whether mKeima-LC3B could become a useful tool to monitor the autophagy-endolysosomal system *in vitro*. MEFs derived from wild-type, GFP-LC3-tg and mKeima-LC3B-tg (line BDKLC3_17--1) mice were subjected to autophagic-flux analysis, in which LC3-II levels in the presence or absence of lysosomal inhibitors were used as "autophagomometer" \[[@pone.0234180.ref008]\]. Under starved conditions, levels of LC3-I, including GFP-LC3-I, mKeima-LC3B-I and endogenous LC3-I, were gradually decreased over time ([Fig 6A](#pone.0234180.g006){ref-type="fig"}). Further, level of SQSTM1 in mKeima-LC3B-expressing MEFs was initially decreased followed by restoring back to the basal level during prolonged starvation ([Fig 6A](#pone.0234180.g006){ref-type="fig"}), consistent with the previous report \[[@pone.0234180.ref026]\]. When cells were treated with CQ, levels of GFP-LC3-II and mKeima-LC3B-II were increased ([Fig 6A](#pone.0234180.g006){ref-type="fig"}). Further, endogenous LC3-II in all tested cell types were comparably increased ([Fig 6A](#pone.0234180.g006){ref-type="fig"}). These results indicate that degree of autophagic clearance was affected by neither GFP-LC3 nor mKeima-LC3B overexpression, and thus that mKeima-LC3B-tg-derived MEFs can normally respond to starvation like do GFP-LC3-tg-derived MEFs.

![Effects of starvation on mKeima-LC3B fusion protein in MEFs.\
(A) Western blot analysis of GFP-LC3 and mKeima-LC3B (top panel), endogenous LC3 (2^nd^ panel) and SQSTM1 (3^rd^ panel). MEFs prepared from GFP-LC3-tg, mKeima-LC3B-tg (BDKLC3_17--1) and wild-type mice were cultured in DMEM followed by incubation in EBSS with or without 50 μM chloroquine (CQ) for indicated time-periods. Two-point three (2.3) μg of total proteins from each sample was subjected to SDS-PAGE and analyzed by immunoblotting using anti-LC3 and anti-SQSTM1 antibodies. β-actin was used for a loading control. Positions of GFP-LC3-I and -LC3-II are shown on the left. Positions of mKeima-LC3B-I and -LC3-II, endogenous LC3-I and LC3-II, and SQSTM1 are shown on the right. White arrowheads shown on the right indicate a possible truncated mKeima-LC3B (indicated as mKeima-LC3'). Size-markers are shown on the left. (B) Flow cytometric analysis of the fluorescent signals in wild-type (WT) MEFs treated with EBSS. Four quadrants (Q1-Q4) were　assigned based on the distribution of background signals observed in WT MEFs, in which Q4 contained the maximum number of cells within its minimum area. (C) Flow cytometric analysis of the mKeima-derived fluorescent signals in mKeima-LC3B-expressing MEFs. Data of MEFs treated with DMEM, DMEM + 50 μM CQ and EBSS (starvation) are shown. Horizontal and vertical axes indicate the emission signal intensities of mKeima at neutral (Comp-Qdot 655-A) and acidic (Comp-PE-Tx-Red-YG-A) pH, respectively. (D) Comparative analysis of the mKeima-derived fluorescent signals obtained from panel B.](pone.0234180.g006){#pone.0234180.g006}

To confirm whether mKeima-LC3B fusion protein would show pH-dependent fluorescence signals as anticipated \[[@pone.0234180.ref020]\], we analyzed the pH-sensitivity of mKeima-LC3B in mKeima-LC3B-expressing MEFs. After fixation, fluorescence signals for mKeima were first detected, and then fixed cells were treated with buffer solutions with different pH, followed by detecting fluorescence signals again. For comparison, we also obtained the images for living-cells treated with DMEM or EBSS. As a result, pH-dependent changes in mKeima-emitted fluorescence signals representing either neutral pH (excitation at 458nm) or acidic pH (excitation at 561nm) were demonstrated, in which ratio of acidic/neutral signals were significantly changed in a pH-dependent manner, particularly in the range between pH5 and pH8 ([S3 Fig](#pone.0234180.s003){ref-type="supplementary-material"}). Based on these data, mKeima-LC3B could monitor a wide range of the maturation step of autophagosomes into autolysosomes. Further, it was speculated that the pH value of mKeima-LC3B-containing compartments under nutrient-rich conditions in living cells ranged from pH6 to pH7, while those under starvation conditions were around pH5 ([S3 Fig](#pone.0234180.s003){ref-type="supplementary-material"}). Together, mKeima-LC3B fusion protein properly shows pH-dependent fluorescence signals as previously reported \[[@pone.0234180.ref020]\].

To determine whether mKeima-LC3B-based monitoring for the autophagy-endolysosomal system was compatible with high-throughput approaches, we analyzed mKeima-LC3B-expressing MEFs using a flow cytometer. A clear shift in acidic/neutral ratio of detected clusters were observed in live-cell analysis, in which neutral signal-dominated (Q1; 0.1%, Q3; 85.5%) and acidic signal-dominated (Q1; 15.9%, Q3; 8.3%) distributions were detected under autophagy-suppressed (DMEM+CQ) and starved (EBSS) conditions, respectively, when compared to normal nutrient-rich conditions (DMEM) (Q1; 4.9%, Q3; 38.1%) ([Fig 6B--6D](#pone.0234180.g006){ref-type="fig"}). These results demonstrate that flow cytometry-based live-cell analysis of mKeima-LC3B can be applicable to high-throughput screening approaches. Collectively, in contrast to *in vivo* ([Fig 4](#pone.0234180.g004){ref-type="fig"}), mKeima-LC3B must be a useful molecular reporter to monitor the autophagy-endolysosomal system under cultured conditions *in vitro*.

Live-cell imaging of mKeima-LC3B-expressing MEFs under nutrient-rich and starvation conditions {#sec024}
----------------------------------------------------------------------------------------------

To clarify the intracellular behavior of mKeima-LC3B under nutrient-rich and starvation conditions, we conducted a live-cell imaging of mKeima-LC3B in mKeima-LC3B-expressing MEFs. We adopted an experimental setting in which cultured medium was repeatedly replaced from DMEM (nutrient-rich) to EBSS (starvation), and then from EBSS back to DMEM. First, we confirmed that medium change process itself did not affect the acidic/neutral signal ratio of mKeima-LC3B-positive compartments ([S1 Movie](#pone.0234180.s006){ref-type="supplementary-material"} and [S2 Movie](#pone.0234180.s007){ref-type="supplementary-material"}). Surprisingly, when cultured medium was repeatedly switched, acidic/neutral signal ratios were rapidly and reversibly changed, indicating that pH in mKeima-LC3B-localizing compartments was dynamically interchangeable between neutral and acidic ranges ([Fig 7A](#pone.0234180.g007){ref-type="fig"}, [Fig 8A](#pone.0234180.g008){ref-type="fig"}, [S3 Movie](#pone.0234180.s008){ref-type="supplementary-material"} and [S4 Movie](#pone.0234180.s009){ref-type="supplementary-material"}).

![Effects of starvation on mKeima-LC3B-positive vesicular compartments in MEFs.\
(A) Representative images of mKeima-LC3B-expressing MEFs. MEFs prepared from mKeima-LC3B-tg mice (BDKLC3_17--1) were cultured in DMEM. After incubation in DMEM for 2 min, medium was repeatedly changed from DMEM to EBSS and from EBSS to DMEM every 80 sec. Images in each row represent as follows: upper row; Neutral (mKeima; ex. 458 nm, green), 2^nd^ row; Acidic (mKeima; ex. 561 nm, red), 3^rd^ row; Merge (mKeima; Neutral + Acidic) and lower row; ratio \[mKeima; 561 nm (Acidic)/458 nm (Neutral)\]. Scale bars indicate 40 μm. (B) Representative images of mKeima-LC3B and LysoTracker double-positive vesicles. MEFs prepared from mKeima-LC3B-tg mice were cultured in DMEM. After incubation in DMEM for 1 min, medium was repeatedly changed from DMEM to EBSS and from EBSS to DMEM every 80 sec. Images in each row represent as follows: upper row; Neutral (mKeima; ex. 458 nm, green), 2^nd^ row; Acidic (mKeima; ex. 561 nm, red), 3^rd^ row; Merge (mKeima; Neutral + Acidic), 4^th^ row; ratio \[mKeima; 561 nm (Acidic)/458 nm (Neutral)\], 5^th^ row; LysoT (LysoTracker blue; ex. 405 nm, blue) and lower row; Merge \[mKeima (Neutral + Acidic) + LysoTracker blue\]. Scale bars indicate 20 μm. (C) Representative high-resolution images of mKeima-LC3B-positive vesicles by Airyscan analysis. Merged images (mKeima; Neutral + Acidic) are shown. Scale bars indicate 0.5 μm.](pone.0234180.g007){#pone.0234180.g007}

![Live-cell analysis of MEFs expressing mKeima-LC3B.\
(A) Representative live-cell time-lapse images of MEFs expressing mKeima-LC3B (related to [Fig 7A](#pone.0234180.g007){ref-type="fig"}). MEFs prepared from mKeima-LC3B-tg mice (BDKLC3_17--1) were cultured in DMEM. After incubation in DMEM for 2 min, medium was repeatedly changed from DMEM to EBSS and from EBSS to DMEM every 80 sec. Images (Z-stack = 2) were captured every 4 sec. Images in each row represent as follows: upper row; Neutral (mKeima; ex. 458 nm, green), 2^nd^ row; Acidic (mKeima; ex. 561 nm, red), 3^rd^ row; Merge (mKeima; Neutral + Acidic) and lower row; ratio \[mKeima; 561 nm (Acidic)/458 nm (Neutral)\]. Lap-times and medium conditions are shown in the top and bottom, respectively. (B) Representative high-resolution live-cell time-lapse images of mKeima-LC3B-positive vesicles under transitional conditions from nutrient-rich (DMEM) to starvation (EBSS) and from starvation (EBSS) to nutrient-rich (DMEM) states (related to [Fig 7C](#pone.0234180.g007){ref-type="fig"}). Images were captured every 300 msec. Lap-times are shown in the top. Blue and pink bars shown in the bottom indicate the incubation period with DMEM and EBSS, respectively. Gray bar indicates the period of medium exchange. (C) Quantitative analysis of changes in mKeima-derived fluorescent signal ratio (Acidic/Neutral) under transitional conditions from nutrient-rich (DMEM) to starvation (EBSS) and from starvation (EBSS) to nutrient-rich (DMEM) states. Data were captured for a total of 500 sec at 1 sec intervals \[observed field; n = 39 (total number of cells; n ≈ 480)\]. Values are expressed as mean ± (S.E.M.).](pone.0234180.g008){#pone.0234180.g008}

To confirm whether the fluctuations observed in mKeima-LC3B-positive signals actually reflected the changes in the intralumenal pH, we performed a simultaneous staining with acidic vesicles with LysoTracker. As expected, a majority of perinuclear LysoTracker-positive vesicles representing late-endosomes, amphisomes and/or autolysosomes were also mKeima-LC3 positive. Further, they similarly showed pH-dependent fluorescence signals upon changes in cultured media ([Fig 7B](#pone.0234180.g007){ref-type="fig"}, [S4 Fig](#pone.0234180.s004){ref-type="supplementary-material"}, [S5 Movie](#pone.0234180.s010){ref-type="supplementary-material"}, [S6 Movie](#pone.0234180.s011){ref-type="supplementary-material"} and [S7 Movie](#pone.0234180.s012){ref-type="supplementary-material"}). Notably, under prolonged starvation conditions; i.e., 60 to 120 min in EBSS, acidic signals in mKeima-LC3B-/LysoTracker-positive vesicle compartments were further increased ([Fig 7B](#pone.0234180.g007){ref-type="fig"}), which was fully consistent with previous findings \[[@pone.0234180.ref018]\]. These data suggest that a rapid and reversible change of pH in LC3-positive autophagosomes and/or amphisomes may precede the vesicle-fusion-based gradual acidification and maturation of autolysosomes.

Next, to further confirm such notions, we conducted a live-cell imaging using a high-resolution Airyscan analysis and investigated the more detailed behavior of mKeima-LC3B-positive vesicles. Under nutrient-rich conditions (DMEM), acidic/neutral ratio of fluorescence signals in mKeima-LC3B-positive vesicles was unchanged ([S8 Movie](#pone.0234180.s013){ref-type="supplementary-material"}). Under repeated-exchanging conditions between nutrient-rich and starvation, acidic/neutral signal ratio was rapidly and reversibly changed, in which the signal shifts of the inner-side of vesicular membrane were more evident than those of the cytoplasmic face ([Fig 7C](#pone.0234180.g007){ref-type="fig"}, [Fig 8B](#pone.0234180.g008){ref-type="fig"} and [S9 Movie](#pone.0234180.s014){ref-type="supplementary-material"}). Notably, such changes seemed to occur autonomously without committing the vesicular fusion ([Fig 7C](#pone.0234180.g007){ref-type="fig"}, [Fig 8B](#pone.0234180.g008){ref-type="fig"} and [S9 Movie](#pone.0234180.s014){ref-type="supplementary-material"}). Quantification of these signal shifts using a high-content analysis revealed that increased signal ratio by starvation reached maximum level within \~20 sec after challenging starvation medium ([Fig 8C](#pone.0234180.g008){ref-type="fig"} and [S5 Fig](#pone.0234180.s005){ref-type="supplementary-material"}). Further, such acidic signals were reversed within \~10 sec when medium returned to nutrition-rich one ([Fig 8C](#pone.0234180.g008){ref-type="fig"}). These results indicate that intraluminal pH of mKeima-LC3B-positive vesicles is rapidly changeable upon nutritional conditions of culture media.

Finally, to test whether these rapid and reversible changes in intraluminal pH of mKeima-LC3B-positive vesicles were associated with genuine maturation of autophagosomes and/or endosomes, we conducted a live-cell imaging as well as quantification of acidic/neutral signals for mKeima-LC3B in the presence or absence of CQ. Treatment with CQ resulted in a gradual decrease of acidic/neutral signal ratio, whose levels were reached to minimum over \~ 6 min of CQ treatment ([Fig 9A](#pone.0234180.g009){ref-type="fig"} and [S10 Movie](#pone.0234180.s015){ref-type="supplementary-material"}), indicating that deacidification by CQ proceeded much slower than did by medium switch from EBSS to DMEM. Interestingly, when the medium was changed from DMEM to EBSS+CQ, prior to CQ-dependent deacidification, a rapid and transient acidification was still observed ([Fig 9B](#pone.0234180.g009){ref-type="fig"} and [S11 Movie](#pone.0234180.s016){ref-type="supplementary-material"}). Fully-acidified mKeima-LC3B-positive vesicles by EBSS were also similarly deacidified by CQ ([Fig 9C](#pone.0234180.g009){ref-type="fig"}, [Fig 9D](#pone.0234180.g009){ref-type="fig"}, [S12 Movie](#pone.0234180.s017){ref-type="supplementary-material"} and [S13 Movie](#pone.0234180.s018){ref-type="supplementary-material"}). Further, vesicles under fully-deacidified conditions by CQ were rapidly reacidified by EBSS treatment ([Fig 9E](#pone.0234180.g009){ref-type="fig"}, [Fig 9F](#pone.0234180.g009){ref-type="fig"}, [S14 Movie](#pone.0234180.s019){ref-type="supplementary-material"} and [S15 Movie](#pone.0234180.s020){ref-type="supplementary-material"}). Notably, MEFs with persistent exposure to CQ were totally unresponsive to the medium switch from DMEM to EBSS; i.e., from DMEM+CQ to EBSS+CQ ([S16 Movie](#pone.0234180.s021){ref-type="supplementary-material"}). These results suggest that a rapidly changeable intraluminal pH of mKeima-LC3B-positive vesicles depends, at least in part, on the process of the authentic vacuolar-type H+-ATPase (V-ATPase)-linked maturation system of autophagosomes and/or endosomes \[[@pone.0234180.ref027]\].

![Quantitative analysis of changes in mKeima-derived fluorescent signal ratio in the presence of chloroquine.\
Changes in mKeima-derived fluorescent signal ratio (Acidic/Neutral) under transitional conditions from (A) nutrient-rich (DMEM) to DMEM + 50 μM chloroquine (CQ) (observed field; n = 5, total number of cells; n ≈ 60), (B) DMEM to starvation (EBSS) +CQ (observed field; n = 4, total number of cells; n ≈ 50), (C) EBSS to DMEM + CQ (observed field; n = 6, total number of cells; n ≈ 70), (D) EBSS to EBSS + CQ (observed field; n = 4, total number of cells; n ≈ 50), (E) DMEM + CQ to DMEM (observed field; n = 7, total number of cells; n ≈ 70) and (F) DMEM + CQ to EBSS (observed field; n = 5, total number of cells; n ≈ 60) states are shown. Values are expressed as mean ± (S.E.M.).](pone.0234180.g009){#pone.0234180.g009}

Discussion {#sec025}
==========

We here established a number of tg mouse lines that were expressing the mKeima-LC3B chimeric protein as a possible novel means for monitoring the autophagy-endolysosomal system. By conducting a series of *in vivo* as well as *in vitro* experiments, we revealed that mKeima-LC3B could be a sensitive reporter molecule for monitoring the autophagy-endolysosomal system under *in vitro* cultured conditions. However, the use of mKeima-LC3B-tg mice may not be appropriate due to an aggregate-prone nature of overexpressed mKeima-LC3B *in vivo*, particularly in the brain.

Since dysfunction of the autophagy-endolysosomal system is thought to be associated with many pathological conditions such as cancer, inflammation and neurodegenerative diseases, it must be very important to properly and precisely understand each step of the autophagy-endolyosomal system, which includes the autophagosome formation, maturation and degradation. Thus far, LC3 tagged with a green fluorescent protein, GFP-LC3, has mostly been utilized to detect the formation of autophagosomes not only in cells but also at an *in vivo* level \[[@pone.0234180.ref009]\]. Nonetheless, there are still some shortcomings to monitor the flux throughout the entire autophagic system using this fusion protein due to its vulnerability to acidic conditions. To overcome such weaknesses, a number of improved molecular probes, such as RFP-GFP-LC3 \[[@pone.0234180.ref012]--[@pone.0234180.ref014]\], mCherry-EGFP-LC3 \[[@pone.0234180.ref015]\], GFP-LC3-RFP-LC3ΔG \[[@pone.0234180.ref016]\], mTagRFP-mWasabi-LC3 \[[@pone.0234180.ref017]\] and pHluorin-mKate2-tagged LC3 \[[@pone.0234180.ref018]\], has been developed thus far. In this study, we newly developed an alternative marker; i.e., mKeima-LC3B, for monitoring the autophagy-endolysosomal activity, and investigated its usefulness in *in vivo* animal as well as *in vitro* cell culture studies.

Previously, it has been shown that GFP-LC3-expressing tg mice is a useful tool to study autophagic responses to starvation *in vivo* \[[@pone.0234180.ref009]\]. We and others have also demonstrated that GFP-LC3 emerges as a sensitive molecular marker to monitor the progression of disease in an ALS mouse model *in vivo* \[[@pone.0234180.ref010], [@pone.0234180.ref011]\]. Therefore, to prove as to whether mKeima-LC3B could response to stresses including food deprivation and neurodegeneration, we conducted a series of *in vivo* studies. Unexpectedly, our results clearly demonstrated that unlike endogenous LC3 or GFP-LC3, mKeima-LC3B did not properly respond to these stresses, even though autophagy itself was dysregulated in corresponding mice. Notably, extended expression of mKeima-LC3B rather seemed to result in accelerated proteolytic stresses, particularly, in the CNS. Since the mKeima protein may have some intrinsically aggregate-prone properties conferring resistance to acidic conditions \[[@pone.0234180.ref020]\], it is speculated that mKeima-LC3 is less-efficiently degraded in autolysosomes and/or lysosomes as previously reported \[[@pone.0234180.ref028]\]. Taken together, mKeima-fused LC3-expressing animals may not be an appropriate tool to monitor the autophagy-endolysosomal system under stressed conditions *in vivo*.

Contrary to *in vivo* experiments, we were able to show that mKeima-LC3B could be utilized to sensitively monitor the dynamic changes of maturation states in the autophagy-endolysosomal system in cultured cells. It has been reported that pH value of the cytosol ranges between 7.2 and 7.6 \[[@pone.0234180.ref029], [@pone.0234180.ref030]\]. It is also estimated that the intralumenal pH of nascent autophagosomes is close to that of the cytosol. On the other hand, the intralumenal pH of other organelle and vesicles are varied, in which the endoplasmic reticulum, cis-Golgi, trans-Golgi, secretory vesicles, early endosomes, recycling endosomes, late endosomes and lysosomes are estimated to be \~7.2, \~6.7, \~6.0, 5.2--5.7, \~6.3, \~6.5, \~6.0 and \~5.5, respectively \[[@pone.0234180.ref031]\]. Since ratio of the bimodal excitation fluorescent spectrum (acidic/neutral) of mKeima-LC3B allowed to determine the approximate pH values ranging between pH5 and pH8, estimating the maturation states of mKeima-LC3B-resided compartments, especially autophagosomes, endosomes and lysosomes, in cells might be possible. Indeed, in this study, we can estimate that the pH value of mKeima-LC3B-containing compartments in living MEFs under nutrient-rich conditions ranges from pH6 to pH7, while those under starvation conditions are around pH5.

One of the remarkable findings in this study is that although the full maturation of autophagosomes by the fusion with lysosomes seems to be slow (in a range of hours) as has previously been reported \[[@pone.0234180.ref018]\], changes of pH in mKeima-LC3B-positive vesicles is rather very rapid (in a range of seconds). Furthermore, to our surprise, the intraluminal pH of mKeima-LC3B-positive vesicles is reversibly changeable upon nutritional conditions of culture media. Importantly, these shifts are completely suppressed by the CQ treatment. Thus, a rapid and reversible change of pH in mKeima-LC3-positive autophagosomes observed in this study is likely to rely on the function of genuine vesicular proton pumps, which may precede the vesicle-fusion-based gradual acidification and ultimate irreversible maturation of autolysosomes.

It has been well studies on the relationship between amino acid starvation and the activation of autophagy \[[@pone.0234180.ref001]\]. Amino acid starvation promotes the formation of unc-51-like kinase 1 (ULK1)-/LC3-/SQSTM1-positive nascent autophagosomes, which is regulated by the mechanistic target of rapamycin (mTOR) complex 1 (mTORC1)-mediated sensing of amino acids. Resulting autophagosomes sequentially mature through multiple steps comprising of vesicle fusion with endosomes (to form amphisomes) and/or lysosomes (to form autolysosomes). Over such maturation steps, the vesicular proton pump V-ATPase, which is localized not only on lysosomal membrane but also on most of endocytic vesicles, plays an essential role in the intralumenal acidification \[[@pone.0234180.ref027]\]. Activity of V-ATPase is regulated by many different mechanisms, which includes the association of the catalytic V~1~ domain with the membrane-associated V~0~ domain, the coupling efficiency between ATP hydrolysis and proton translocation, and the interaction with specific lipid environments \[[@pone.0234180.ref032]\]. Recently, it has been revealed that a reversible assemble of V-ATPase; i.e., the association and dissociation of V~1~ and V~0~, in response to the changes in amino acid levels is linked to the luminal pH and the catalytic activity of V-ATPase, but not to the phosphatidylinositol-3 kinase (PI3K) and mTORC1 activities \[[@pone.0234180.ref033]\]. Thus, since autophagosome-lysosome fusion itself is also independent of the V-ATPase-mediated acidification \[[@pone.0234180.ref034]\], it is highly likely that the activation of V-ATPase prior to lysosome fusion leads to rapid acidification of mKeima-LC3B-positive vesicles. However, at present, the exact molecular pathway, which is responsible for the amino acid starvation-induced activation of V-ATPase and thus rapid acidification (\~ within 20 sec) of these vesicles, remains unclear.

One perplexing but important question arising from this study includes as to how a rapid deacidification (\~ within 10 sec) of mKeima-LC3B-resided compartments occurs by changing the media from EBSS back to DMEM. When we added CQ to cell cultures, the deacidification of mKeima-LC3B-positive vesicles gradually and directionally proceeded from the peripheral to center of the cell over \~6 min (see [Fig 9D](#pone.0234180.g009){ref-type="fig"} and [S13 Movie](#pone.0234180.s018){ref-type="supplementary-material"}), indicative of a slow penetration of CQ into the cells. Conversely, it is reasonable to assume that rapid and synchronized deacidification of mKeima-LC3B-positive vesicles is rather mediated by virtue of a certain signaling pathway to sense the amino acid repletion in culture media. Thus far, besides V-ATPase, the alkali cation/proton exchanger SLC9A6/NHE6, whose mutations are linked to Christianson syndrome, is known to be implicated in the intraluminal pH homeostasis in endocytic vesicles, namely in recycling endosomes \[[@pone.0234180.ref035]\]. However, to the best of our knowledge, there have been no studies demonstrating the active-deacidification of autophagosomes and/or endocytic vesicles. On the other hand, it has been reported that the activity of V-ATPase itself in the endocytic pathway is reversibly regulated \[[@pone.0234180.ref032]\]. Interestingly, the intracellular concentration of calcium ions was also reversibly changed by responding to the presence and/or absence of amino acids in culture media, in which the addition and withdrawal of amino acids result in decrease and increase of intracellular calcium concentrations, respectively \[[@pone.0234180.ref036]\]. Although the authors in this interesting study have claimed that increased calcium ions activate Ca^2+^/calmodulin-dependent kinase kinase (CaMKK) and AMP-activated protein kinase (AMPK) with concomitant inhibition of mTORC1, thereby inducing autophagy (in a range of hours), the response of decrease in the intracellular calcium concentration to amino acid supplement was, in fact, remarkably rapid (in a range of seconds) \[[@pone.0234180.ref036]\] as we observed in DMEM-induced rapid deacidification. It is also notable that the vesicular pH (pH6-7) is further shifted towards alkaline pH (\~pH8) when CQ is added to DMEM (see [Fig 9A](#pone.0234180.g009){ref-type="fig"} and [S10 Movie](#pone.0234180.s015){ref-type="supplementary-material"}), indicating that the moderate but persistent activation of V-ATPase occurs to maintain the physiological pH (pH6-7) in autophagosomes and/or endocytic vesicles even under nutrition-rich conditions.

Based on these notions, we hypothesize two possible mechanisms to explain the rapid deacidification of mKeima-LC3B-resided compartments by changing culture media from EBSS to DMEM. First, amino acid repletion can trigger a rapid decline of the V-ATPase activity via certain signaling pathways; e.g., calcium ion-mediated signaling. Consequently, the ability to maintain an intraluminal acidity is instantly lost, resulting in autophagosomes and/or endocytic vesicles with homeostatic neutral pH (pH6-7) within \~10 sec. Second, there may exist a yet-to-be-identified active deacidification mechanism that responds to extracellular amino acids. However, at this stage, we could not fully explain the mechanism and/or signaling pathway for these rapid-reversible phenomena in an evidence-based manner.

Another issue that has yet to be addressed is the exact and/or precise definition of the mKeima-LC3B-labeled compartments. It has been well described that endocytic pathway and autophagic pathway are interrelated \[[@pone.0234180.ref037], [@pone.0234180.ref038]\]. In addition, several recent studies have demonstrated that LC3-positive vesicles include not only autophagosomes and amphisomes \[[@pone.0234180.ref021]\] but also endosomes derived through distinct endocytic pathways, such as LC3-associated phagocytosis (LAP) \[[@pone.0234180.ref039]\], LC3-associated endocytosis (LANDO) \[[@pone.0234180.ref040]\] and LC3-conjugated multivesicular bodies containing extracellular vesicles to be secreted \[[@pone.0234180.ref041]\]. Thus, it is possible that mKeima-LC3B-positive vesicles include other than autophagosomes and/or amphisomes. To precisely and distinctly define mKeima-LC3B-positive compartments, development an additional set of specific vesicular markers with fluorophore, which can be simultaneously used with mKeima, will be required.

In conclusions, the intralumenal pH of mKeima-LC3B-residing compartments, probably autophagosomes, endosomes and autolysosomes, can be rapidly and reversibly changed upon nutritional conditions. Currently, it has been believed that the maturation of autophagosomes toward autolysosomes and/or lysosomes is the one-way directional pathway \[[@pone.0234180.ref001], [@pone.0234180.ref006], [@pone.0234180.ref007]\]. However, it is possible that at some stages of maturation, autophagosomes and/or endosomes still place in undetermined fate before tilting toward the irreversible maturation step of vesicular compartments. Currently, the physiological meaning of such reversible rapid changes of the intralumenal pH is unclear. In order to answer these questions, further studies will be required. Detailed characterization of autophagosome maturation step by using mKeima-LC3B as a molecular probe will give us more clues to understanding the autophagy-endolysosomal process in the manifestation of many physiological as well as pathological conditions.

Supporting information {#sec026}
======================

###### Schematic diagram of transgene construct for mKeima-LC3B transgenic mouse.

Transgene construct consists of cytomegalovirus enhancer (E), chicken β-actin promoter (Pro), rabbit β-globin splice acceptor (S), mKeima-Red cDNA, full-length human MAP1LC3B cDNA (LC3B), and rabbit β-globin poly A (Poly A). Positions of restriction enzymes used for cloning and primers for genotyping are shown.

(TIF)

###### 

Click here for additional data file.

###### Immunohistochemical analysis of LC3 in tissues from wild-type and mKeima-LC3B transgenic mice under starvation conditions.

\(A\) Cerebral cortex, (B) hippocampus, (C) cerebellum, (D) pons (facial nucleus), and (E) lumbar spinal cord (L4-L5), which were prepared from wild-type and mKeima-LC3B transgenic (tg) mice under either fed (control) or starved (48 h) conditions, were fixed and immunostained with anti-LC3 (α-LC3) or anti-mKeima (α-mKeima) antibody. Mouse lines used in this analysis were (A-D) BDKLC3_17--1 and (E) KLC3_44. Scale bars indicate (A, a-f) 200 μm, (A, g-l) 100 μm, (B, a-f) 200 μm, (B, g-l) 100 μm, (C, a-f) 200 μm, (C, g-l) 100 μm, (D, a-f)) 200 μm, (D, g-l) 100 μm, and (E) 200 μm.

(TIF)

###### 

Click here for additional data file.

###### The pH sensitivity of mKeima-LC3B.

After fixation, fluorescent signals for mKeima in mKeima-LC3B-expressing MEFs, which were prepared from mKeima-LC3B-tg mice (BDKLC3_17--1), were detected (Pre). Then, fixed cells were buffered at (A) pH 4.0, (B) pH 5.0, (C) pH 6.0, (D) pH 7.0, (E) pH 8.0, or (F) pH 9.0, or treated with (G) EBSS (pH 7.4--7.6), followed by detection of fluorescent signals (Post). (H) For comparison, images for living cells treated with DMEM or EBSS are shown. Scale bars indicate 50 μm.

(TIF)

###### 

Click here for additional data file.

###### Representative live-cell time-lapse images of MEFs expressing mKeima-LC3B.

MEFs prepared from mKeima-LC3B tg mice (BDKLC3_17--1) were cultured in DMEM. After incubation in DMEM for 1 min, medium was repeatedly changed from DMEM to EBSS and from EBSS to DMEM every 80 sec. Images (Z-stack = 1) were captured every 2.5 sec. Images in each row represent as follows: upper row; Neutral (mKeima; ex. 458 nm, green), 2^nd^ row; Acidic (mKeima; ex. 561 nm, red), 3^rd^ row; Merge (mKeima; neutral + acidic), 4^th^ row; ratio \[mKeima; 561 nm (acidic)/458 nm (neutral)\], 5^th^ row; LysoT (LysoTracker blue; ex. 405 nm, blue), and lower row; Merge \[mKeima (neutral + acidic) + LysoTracker blue\]. Lap-times and medium conditions are shown in the top and bottom, respectively. As a negative control, images of wild-type MEFs cultured in DMEM are also shown. Scale bar indicates 20 μm.

(TIF)

###### 

Click here for additional data file.

###### Quantitative analysis of changes in mKeima-derived fluorescent signal ratio (related to [Fig 8](#pone.0234180.g008){ref-type="fig"}).

Changes in mKeima-derived fluorescent signal ratio (Acidic/Neutral) under transitional conditions from nutrient-rich (DMEM) to starvation (EBSS) states are shown. Two independent experiments, in which data were captured for 100 sec at 1 sec intervals \[EBSS 1^st^ (magenta circle); observed field; n = 29 (total number of cells; n ≈ 350) and EBSS 2^nd^ (yellow circle); observed field; n = 55 (total number of cells; n ≈ 670)\], were performed. Signal ratio under nutrient-rich conditions \[DMEM (blue circle); observed field; n = 50 (total number of cells; n ≈ 610)\] was also monitored as a control. Values are expressed as mean ± (S.E.M.).

(TIF)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under conditions with repeated changes in nutrient-rich medium (DMEM).

After incubation in DMEM for 60 min, medium was changed from DMEM to fresh DMEM. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under conditions with repeated changes in starvation medium (EBSS).

After incubation in EBSS for 60 min, medium was changed from EBSS to fresh EBSS. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under nutrient-rich conditions (DMEM) (related to Figs [7](#pone.0234180.g007){ref-type="fig"} and [8](#pone.0234180.g008){ref-type="fig"}).

Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 4 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under conditions with repeated changes in media between nutrient-rich (DMEM) and starvation (EBSS) states (related to Figs [7](#pone.0234180.g007){ref-type="fig"} and [8](#pone.0234180.g008){ref-type="fig"}).

After incubation in DMEM for 2 min, medium was repeatedly changed from DMEM to EBSS and from EBSS to DMEM every 80 sec. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 4 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under conditions with repeated changes in media between nutrient-rich (DMEM) and starvation (EBSS) states (related to [Fig 7](#pone.0234180.g007){ref-type="fig"}).

After incubation in DMEM for 1 min, medium was repeatedly changed from DMEM to EBSS and from EBSS to DMEM every 80 sec. Images for LysoTracker blue (Z-stack = 1) (blue) were captured every 2.5 sec. Scale bar indicates 10 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under nutrient-rich conditions (DMEM) (related to [Fig 7](#pone.0234180.g007){ref-type="fig"}).

Merged images (Z-stack = 1) for signals of mKeima \[neutral (green) and acidic (red)\] and LysoTracker blue (blue) were captured every 2.5 sec. Scale bar indicates 10 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under conditions with repeated changes in media between nutrient-rich (DMEM) and starvation (EBSS) states (related to [Fig 7](#pone.0234180.g007){ref-type="fig"}).

After incubation in DMEM for 1 min, medium was repeatedly changed from DMEM to EBSS and from EBSS to DMEM every 80 sec. Merged images (Z-stack = 1) for signals of mKeima \[neutral (green) and acidic (red)\] and LysoTracker blue (blue) were captured every 2.5 sec. Scale bar indicates 10 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of mKeima-LC3B-positve vesicles under nutrient-rich conditions (DMEM) (related to Figs [7](#pone.0234180.g007){ref-type="fig"} and [8](#pone.0234180.g008){ref-type="fig"}).

Merged images for mKeima signals \[neutral (green) and acidic (red)\] were captured every 300 msec. Scale bar indicates 0.5 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of mKeima-LC3B-positve vesicles under conditions with repeated changes in media between nutrient-rich (DMEM) and starvation (EBSS) states (related to Figs [7](#pone.0234180.g007){ref-type="fig"} and [8](#pone.0234180.g008){ref-type="fig"}).

Medium was repeatedly changed from DMEM to EBSS and from EBSS to DMEM every 80 sec. Merged images for mKeima signals \[neutral (green) and acidic (red)\] were captured every 300 msec. Scale bar indicates 0.5 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under transitional conditions from nutrient-rich (DMEM) to DMEM + 50 μM chloroquine (CQ) states (related to [Fig 9A](#pone.0234180.g009){ref-type="fig"}).

After incubation in DMEM for 80 sec, medium was changed from DMEM to DMEM + CQ. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under transitional conditions from nutrient-rich (DMEM) to starvation (EBSS) + 50 μM chloroquine (CQ) states (related to [Fig 9B](#pone.0234180.g009){ref-type="fig"}).

After incubation in DMEM for 80 sec, medium was changed from DMEM to EBSS + CQ. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under transitional conditions from starvation (EBSS) to nutrient-rich (DMEM) + 50 μM chloroquine (CQ) states (related to [Fig 9C](#pone.0234180.g009){ref-type="fig"}).

After incubation in EBSS for 60 min, medium was changed from EBSS to DMEM + CQ. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under transitional conditions from starvation (EBSS) to EBSS + 50 μM chloroquine (CQ) states (related to [Fig 9D](#pone.0234180.g009){ref-type="fig"}).

After incubation in EBSS for 60 min, medium was changed from EBSS to EBSS + CQ. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under transitional conditions from nutrient-rich (DMEM) + 50 μM chloroquine (CQ) to DMEM states (related to [Fig 9E](#pone.0234180.g009){ref-type="fig"}).

After incubation in DMEM + CQ for 60 min, medium was changed from DMEM + CQ to DMEM. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under transitional conditions from nutrient-rich (DMEM) + 50 μM chloroquine (CQ) to starvation (EBSS) states (related to [Fig 9F](#pone.0234180.g009){ref-type="fig"}).

After incubation in DMEM + CQ for 60 min, medium was changed from DMEM + CQ to EBSS. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### A time-lapse movie of MEFs expressing mKeima-LC3B under transitional conditions from nutrient-rich (DMEM) + 50 μM chloroquine (CQ) to starvation (EBSS) + 50 μM chloroquine (CQ) states.

After incubation in DMEM + CQ for 60 min, medium was changed from DMEM + CQ to EBSS + CQ. Merged images (Z-stack = 2) for mKeima signals \[neutral (green) + acidic (red)\] were captured every 5 sec. Scale bar indicates 20 μm.

(MOV)

###### 

Click here for additional data file.

###### Uncropped images for immunoblots.

Immunoreactivities were visualized with Immobilon-Western Chemiluminescent HRP Substrate (Millipore) and analyzed using Ez-Capture Analyzer (ATTO).

(PDF)

###### 

Click here for additional data file.
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The authors tried to develop a new autophagy endolysosomal pathway sensor system using keima red fused to LC3.  Although mKeima-LC3B-tg mice failed to show promising results, mice derived MEF based system proved as a sensitive reporter system. They show convincing images and quantitative data to support the finding.  

1\. The authors analyzed Ph sensitivity of Keima LC3 after fixation. it is better to perform this before fixation.

2\. The study reveals rapid and reversible autonomous change of pH in LC3-positive autophagosomes before the vesicle-fusion. This is an interesting observation needs further validation. The methodology is having potential application in diverse areas of biology including drug screening.
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1\. It is not clear to me what the added value is of adding LC3 to the existing mKeima probe. mKeima is a well-validated autophagy probe that is taken up into autophagosomes after autophagy induction and allows distinction of autophagosomes from lysosomes. What is the advantage of attaching LC3 to mKeima? The rationale for making this fusion construct should be explained much better. 

2\. It is very strange that mKeima-containing acidic vesicles (confirmed to be lysosomes by costaining with LysoTracker) become neutral within 10 seconds after switching from EBSS to DMEM. It seems very unlikely that the proton gradient across the lysosomal membrane can be completely abolished within 10 seconds after this medium switch. Which signaling pathway could possibly explain such rapid de-acidification? This finding seems to hint at some possible artifact related to the medium switch. More data would be required to make this finding more convincing.

3\. The in vivo data in the transgenic mice are not adding much and could be removed from the manuscript
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Reviewer \#1: Yes

Reviewer \#2: No
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2\. Has the statistical analysis been performed appropriately and rigorously?
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3\. Have the authors made all data underlying the findings in their manuscript fully available?
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Reviewer \#1: The authors tried to develop a new autophagy endolysosomal pathway sensor system using keima red fused to LC3. Although mKeima-LC3B-tg mice failed to show promising results , mice derived MEF based system proved as a sensitive reporter system. They show convincing images and quantitative data to support the finding.

The authors analyzed Ph sensitivity of Keima LC3 after fixation. it is better to perform this before fixation.

The study reveal rapid and reversible autonomous change of pH in LC3-positive autophagosomes before the vesicle-fusion. This is an interesting observation needs further validation. The methodology is having potential application in diverse areas of biology including drug screening.

Reviewer \#2: The authors have generated a mKeima-LC3B fusion construct. They have generated transgenic mouse lines expressing this construct to monitor autophagy in vivo, and also performed live imaging in vitro in mouse embryonic fibroblasts derived from the transgenic mice. They conclude that this probe may not be an appropriate tool to monitor autophagy in vivo, but could be very useful for experiments in cultured cells.

The manuscript is well written and the figures have been made with much care, but unfortunately there are some important issues that dampen may enthusiasm:

1\. It is not clear to me what the added value is of adding LC3 to the existing mKeima probe. mKeima is a well-validated autophagy probe that is taken up into autophagosomes after autophagy induction and allows distinction of autophagosomes from lysosomes. What is the advantage of attaching LC3 to mKeima? The rationale for making this fusion construct should be explained much better.

2\. It is very strange that mKeima-containing acidic vesicles (confirmed to be lysosomes by costaining with LysoTracker) become neutral within 10 seconds after switching from EBSS to DMEM. It seems very unlikely that the proton gradient across the lysosomal membrane can be completely abolished within 10 seconds after this medium switch. Which signaling pathway could possibly explain such rapid de-acidification? This finding seems to hint at some possible artifact related to the medium switch. More data would be required to make this finding more convincing.

3\. The in vivo data in the transgenic mice are not adding much and could be removed from the manuscript
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To answer the comments and/or questions provided by the reviewers, we have conducted an additional set of experiments, whose results are exclusively included in our revised manuscript. Comments and questionnaires from reviewers are itemized and accompanied with our answers/responses as bellows.

Reviewer \#1's comments:

1\. The authors analyzed pH sensitivity of Keima LC3 after fixation. it is better to perform this before fixation.

\- Response to this comment:

We appreciate the reviewer's important comment. As suggested by the reviewer, monitoring the pH sensitivity without fixation must be an ideal way to do. However, without fixation, which means the cells still alive, the incubation with acid or alkaline buffer solutions, in particular under extreme pH conditions, is harmful to cells; sometimes resulting in cell death. Under such conditions, analysis of pH sensitivity of expressed mKeima-LC3B may be extremely difficult. In addition, even after fixation, mKeima seems to keep the variable excitation spectra in a pH-dependent fashion. Thus, we are currently believing that the fixation of cells is the best way to stably measure and estimate the pH sensitivity of mKeima-LC3B molecules in situ. Alternatively, it may also be possible to biochemically measure the sensitivities using purified proteins. Indeed, the pH sensitivity of mKeima using purified protein has already been reported in the original publication (Katayama et al, Chem Biol 18: 1042, 2011). However, in our hand, purification of the mKeima-LC3B fusion protein has been unsuccessful thus far. These are the reasons why we have currently adopted the fixed cells in this study.

2\. The study reveals rapid and reversible autonomous change of pH in LC3-positive autophagosomes before the vesicle-fusion. This is an interesting observation needs further validation. The methodology is having potential application in diverse areas of biology including drug screening.

\- Response to this comment:

We appreciate the reviewer's invaluable comments. As pointed out by the reviewer, we have not shown the direct evidence whether a rapid and reversible change of pH in mKeim-LC3B-positive autophagosomes occurs autonomously without committing the vesicle-fusion. Since we were unable to clearly distinguish between nascent/immature and maturated mKeima-LC3B-positive autophagosomes by staining with LysoTracker (see Fig 7), we tried to do an additional set of experiments of a live-cell imaging. Although the pharmacological inhibition of vesicular proton pumps by chloroquine (CQ) resulted in suppression of nutritional-condition-dependent rapid changes in vesicular pH (see S21 movie); yet such suppression was still reversible (see Fig 9F), we had been unable to show the commitment of vesicle fusion by this procedure. Thus, due to lack of sufficient evidences, we decided to decline the over-stated sentences that were describing "the commitment of vesicle fusion" in the phenomena of a rapid and reversible pH changes, in order to avoid the confusion as well as misunderstanding by the readers.

Reviewer \#2's comments:

1\. It is not clear to me what the added value is of adding LC3 to the existing mKeima probe. mKeima is a well-validated autophagy probe that is taken up into autophagosomes after autophagy induction and allows distinction of autophagosomes from lysosomes. What is the advantage of attaching LC3 to mKeima? The rationale for making this fusion construct should be explained much better.

\- Response to this comment:

We appreciate the reviewer's comments. Generally, macroautophagy (autophagy hereafter) is implicated in two different types of degradation; non-selective and selective degradation. Recent evidences have uncovered that dysregulation of the selective cargo-degradation system rather than non-selective one is associated with many pathological conditions such as cancer, inflammation and neurodegenerative diseases, and that LC3 and other autophagy receptor molecules containing the LIR (LC3-interacting region), such as SQSTM1/p62, NBR1 and optineurin, contributes to such disorders. Since LC3 is known to not only directly bind to autophagosomal membranes, but also simultaneously to several autophagy receptors, attaching LC3 molecule to mKeima has a strong advantage to monitor the selective-degradation activity, as has already been shown by many previous publications using GFP-LC3 fusion molecules. By contrast, in the original paper by Katayama et al (Chem Biol 2011), lone mKeima can become a probe for non-selective autophagy but not for selective ones. In this revised manuscript, we added the phrase "the selective cargo-degradation system" in the section of Introduction, to facilitate the proper understanding by the readers.

2\. It is very strange that mKeima-containing acidic vesicles (confirmed to be lysosomes by containing with LysoTracker) become neutral within 10 seconds after switching from EBSS to DMEM. It seems very unlikely that the proton gradient across the lysosomal membrane can be completely abolished within 10 seconds after this medium switch. Which signaling pathway could possibly explain such rapid de-acidification? This finding seems to hint at some possible artifact related to the medium switch. More data would be required to make this finding more convincing.

\- Response to this comment:

We appreciate the reviewer's invaluable comments. First, as already mentioned in response to the Reviewer\#1, we were unable to clearly distinguish between nascent/immature and maturated mKeima-LC3B-positive autophagosomes by staining with LysoTracker (Fig 7). It was also noted that LysoTracker signals were not changed by the DMEM-EBSS medium switch (revised S9 Movie). We are currently speculating that LysoTracker-labeled vesicles represent not only fully matured autolysosomes/lysosomes but also immature autophagosomes/late endosomes as well as amphisomes, which are emerged by a gradual acidification of autophagosomes/endosomes through the activation of vesicular proton pumps.

To further response to the reviewer's questions, we have conducted an additional set of experiments. In order to test whether the medium change itself affected fluorescent signals, we performed a live-cell imaging under repeated changes of the same medium; i.e., DMEM to DMEM, or EBSS to EBSS. Although some signal fluctuations during the medium exchange were observed; which might be due to the deflection of laser-beam by transiently lowering level of medium solution, there were no observable differences in the acid/neutral signal ratio between before and after changing the medium (revised S4 Movie and S5 Movie). Therefore, medium change process itself may not affect the acidic/neutral signal ratio of mKeima-LC3B-positive compartments. Next, to test whether a rapid and reversible change in intraluminal pH of mKeima-LC3B-positive vesicles was associated with genuine maturation of autophagosomes and/or endosomes, we conducted a live-cell imaging as well as quantification of acidic/neutral signals for mKeima-LC3B in the presence or absence of CQ. All the results obtained are exclusively described in a separate paragraph of the Results section and related additional figures and movies were included (Fig 9, S15-S21 Movies). Although the deacidification by CQ proceeded much slower than did by medium switch from EBSS to DMEM, the pharmacological inhibition of vesicular proton pumps by CQ results in suppression of nutritional-condition-dependent rapid changes in vesicular pH (revised S21 movie). Importantly, such suppression was still reversible (revised Fig 9F). The results indicate that a rapidly changeable intraluminal pH of mKeima-LC3B-positive vesicles depends, at least in part, on the process of the authentic maturation system of autophagosomes and/or endosomes.

Based on our results, it is possible that continuous and persistent activation of proton pumps may be required to keep autophagosomes/endosomes towards acidic in their reversible phase. Under nutrition-rich conditions, the proton pump activity may rapidly decline via a certain signaling pathway. Consequently, the ability of maintaining an intraluminal acidity is rapidly lost, resulting in autophagosomes with neutral pH within 10 sec. Conversely, when starved, massive activation of proton pumps may explain a rapid acidification of autophagosomes. Thus far, we could not fully explain the mechanism and/or signaling pathway for these rapid-reversible phenomena in an evidence-based manner. Further studies are warranted as stated in the manuscript.

3\. The in vivo data in the transgenic mice are not adding much and could be removed from the manuscript

\- Response to this comment:

We appreciate the reviewer's important suggestions. As pointed out by the reviewer, the results were rather negative indeed. However, if allowed, we would like to show those data in order to notify the negative side of mKeima molecule in the use of in vivo experiments to the readers.

4\. What is the meaning of the mKeima-LC3' (as opposed to mKeima-LC3) band in the western blot figures?

\- Response to this comment:

We appreciate the reviewer's comments. To avoid the confusion, we clearly added the definition of "mKeima-LC3'" in the legends of Fig 1, Fig 2, Fig 4 and Fig 6.
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Submitted filename: Response_to_Reviewers.docx
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Click here for additional data file.

10.1371/journal.pone.0234180.r003

Decision Letter 1

Trajkovic

Vladimir

Academic Editor

© 2020 Vladimir Trajkovic

2020

Vladimir Trajkovic

This is an open access article distributed under the terms of the
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10 Feb 2020

PONE-D-19-24727R1

Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B

PLOS ONE

Dear Dr. Hadano,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Reviewer 2:

The revised manuscript has not really improved compared with the previous version. The response to my previous comments is not satisfactory.

1\. It remains unclear what the added value is of adding LC3 to the existing mKeima probe. The response of the authors to this comment does not make sense. LC3 is involved in selective as well as non-selective autophagy. The response by the authors that "attaching LC3 molecule to mKeima has a strong advantage to monitor the selective degradation activity" is simply not correct.

2\. The finding that mKeima-containing acidic vesicles become neutral within 10 seconds after switching from EBSS to DMEM remains very strange and the mechanism remains completely unexplained.

==============================

We would appreciate receiving your revised manuscript by Mar 26 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Vladimir Trajkovic

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors have explained the details of the changes made as per the concerns raised by the reviewers. The modified version looks good.

Reviewer \#2: The revised manuscript has not really improved compared with the previous version. The response to my previous comments is not satisfactory.

1\. It remains unclear what the added value is of adding LC3 to the existing mKeima probe. The response of the authors to this comment does not make sense. LC3 is involved in selective as well as non-selective autophagy. The response by the authors that "attaching LC3 molecule to mKeima has a strong advantage to monitor the selective degradation activity" is simply not correct.

2\. The finding that mKeima-containing acidic vesicles become neutral within 10 seconds after switching from EBSS to DMEM remains very strange and the mechanism remains completely unexplained.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0234180.r004

Author response to Decision Letter 1

8 Mar 2020

March 9, 2020

Dr. Vladimir Trajkovic

Academic Editor

PLOS ONE

Dear Dr. Trajkovic,

We greatly appreciate the excellent reviews. A revision of our manuscript (PONE-D-19-24727R1) by Hideki Hayashi et al. has been completed. Please find uploaded files for our revised manuscript entitled "Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B" by Hideki Hayashi, Ting Wang, Masayuki Tanaka, Sanae Ogiwara, Chisa Okada, Masatoshi Ito, Nahoko Fukunishi, Yumi Iida, Ayaka Nakamura, Ayumi Sasaki, Shunji Amano, Kazuhiro Yoshida, Asako Otomo, Masato Ohtsuka and Shinji Hadano. We also attached the manuscript, in which corrections that we made were highlighted as red-colored letters, as a separate file.

To answer the comments and/or questions provided by the reviewer\#2, we have tried to add more detailed explanations with additional citations mainly to the sections of "Introduction" and "Discussion", and at the same time, to refine them as precisely as possible. Comments and questionnaires from reviewers are itemized and accompanied with our answers/responses as bellows.

Reviewer \#2's comments:

1\. It remains unclear what the added value is of adding LC3 to the existing mKeima probe. The response of the authors to this comment does not make sense. LC3 is involved in selective as well as non-selective autophagy. The response by the authors that "attaching LC3 molecule to mKeima has a strong advantage to monitor the selective degradation activity" is simply not correct.

\- Response to this comment:

We appreciate the reviewer's comment. We would like to admit our misunderstanding and totally agree with what the reviewer has pointed-out; i.e., LC3 is involved both in selective and non-selective autophagy. To facilitate the readers' proper understanding of our aim as well as reason as to why the LC3 molecule attached to mKeima, we tried to correct and explain them by adding several sentences to the section of "Introduction" (see lines 68-77 in the correction-highlighted manuscript).

2\. The finding that mKeima-containing acidic vesicles become neutral within 10 seconds after switching from EBSS to DMEM remains very strange and the mechanism remains completely unexplained.

\- Response to this comment:

We appreciate the reviewer's invaluable comments. As the reviewer has pointed out, a phenomenon of the rapid deacidification (\~ within 10 sec) of mKeima-LC3B-resided compartments, which is induced by changing the media from EBSS to DMEM, is also totally unexpected to us. Thus far, to the best of our knowledge, there have been no studies demonstrating the rapid deacidification of autophagosomes and/or endocytic vesicles, let alone the mechanisms of such phenomena. Although data showing such rapid deacidification are reproducibly obtained, at least, by our hand, we honestly say that we do not have enough abilities to clarify their molecular mechanisms as well as physiological significances in an experimental evidence-based manner within a designated period of this revision time. Therefore, in this revision, we decided to add more detailed explanations in the section of "Discussion", and proposed the hypothetical mechanisms that were drawn from the current findings on the acidification and deacidification of endocytic vesicles in conjunction with the regulation of the V-ATPase functions under amino acid deplete as well as replete conditions (see lines 619-670 in the correction-highlighted manuscript). Further, we added a separated paragraph to the section of "Discussion" to explain in more detail on arising issues on LC3-labeled compartments (see lines 671-680 in the correction-highlighted manuscript).

By submitting the manuscript to PLoS ONE, we understand that "the work described has not been submitted for publication, in whole or in part, elsewhere and all the authors listed have approved the manuscript that is enclosed". We understand that "should the submitted material be accepted for publication in PLoS ONE, we will automatically transfer the copyright to the publisher". Further, the authors have declared that no competing interests exist.

We hope that all the changes we made meet your acceptance of the manuscript for publication in PLoS ONE. Thank you for your generous consideration. We are looking forward to hearing from you soon.

Sincerely yours,

Shinji Hadano, Ph.D.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

Professor of Department of Molecular Life Sciences

Tokai University School of Medicine

143 Shimokasuya, Isehara, Kanagawa 259-1193, JAPAN

TEL: +81-463-93-1121 (ext. 2567)

FAX: +81-463-93-3965

E-mail: <shinji@is.icc.u-tokai.ac.jp>
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PONE-D-19-24727R2

Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B

PLOS ONE

Dear Dr. Hadano,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Reviewer 3:

1\. A small issue with Figure 5B, the FACS plot. Four quadrants were assigned (Q1-Q4). They should explain both in text and figure legend how they are drawn and what they actually mean. 

2\. Another issue is Figure 4C and 4H. Starvation induces LC3 lipidation and also p62 degradation. It\'s surprising to see p62 level is increased in starved samples.

==============================

We would appreciate receiving your revised manuscript by Jun 25 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Vladimir Trajkovic

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#3: I\'m a new reviewer so I can\'t answer the first question: if the authors have adequately addressed my comments in a previous round of review\". However, I did see the authors addressed the comments raised by other reviewers. Although I\'m not satisfied with the authors\' explanation on why the acidic/neutral signal ratio of mKeima-LC3 changes so rapidly with media changes, I do recognize that it\'s pretty hard to clearly answer this question. I would have asked the authors to do the experiments in a couple of autophagy defective KO MEFs cells, such as ATG5, FIP200 KO etc. In addition, experiments with mito-mKeima or better with ER-mKeima maker (a recent Cell paper by Jacob Corn lab shows that starvation induces robust ER-phage) may shed more insights on this issue. But it\'s too much to ask for a PLOS ONE paper.

A small issue with Figure 5B, the FACS plot. Four quadrants were assigned (Q1-Q4). They should explain both in text and figure legend how they are drawn and what they actually mean.

Another issue is Figure 4C and 4H. Starvation induces LC3 lipidation and also p62 degradation. It\'s surprising to see p62 level is increased in starved samples.

I recommend the acceptance of this manuscript with the above suggested minor changes.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#3: Yes: Chunxin Wang

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0234180.r006

Author response to Decision Letter 2

19 May 2020

May 20, 2020

Dr. Vladimir Trajkovic

Academic Editor

PLOS ONE

Dear Dr. Trajkovic,

We greatly appreciate the excellent reviews. A revision of our manuscript (PONE-D-19-24727R2) by Hideki Hayashi et al. has been completed. Please find uploaded files for our revised manuscript entitled "Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B" by Hideki Hayashi, Ting Wang, Masayuki Tanaka, Sanae Ogiwara, Chisa Okada, Masatoshi Ito, Nahoko Fukunishi, Yumi Iida, Ayaka Nakamura, Ayumi Sasaki, Shunji Amano, Kazuhiro Yoshida, Asako Otomo, Masato Ohtsuka and Shinji Hadano. We also attached the manuscript, in which corrections that we made were highlighted as red-colored letters, as a separate file.

To answer the comments and/or questions provided by the reviewer\#3, we have slightly modified Fig 6 with the addition of some explanations both to the manuscript and legend. Further, since a new study that was related to the molecule (SLC9A6/NHE6) implicating pH modulation in endosomes had been published after the last submission of our revised manuscript, we additionally included such new findings in Discussion with the citation (as reference \#35).

Reviewer \#3's comments:

1\. A small issue with Figure 5B, the FACS plot. Four quadrants were assigned (Q1-Q4). They should explain both in text and figure legend how they are drawn and what they actually mean.

\- Response to this comment:

We appreciate the reviewer's invaluable comments. In a flow cytometric analysis, we determined the areas of quadrants (Q1-Q4) based on the distribution of background signals observed in wild-type MEFs. Accordingly, we newly added data showing the signal distribution of wild-type MEFs as Fig 6B, and explained how they were determined in its figure legend as well as in the corresponding section of Materials & Methods. Furthermore, to facilitate the proper understanding of the meaning of signal shifts induced by medium changes, the numerical data (showing the percentage of the cell numbers) were also included in the Result section.

2\. Another issue is Figure 4C and 4H. Starvation induces LC3 lipidation and also p62 degradation. It\'s surprising to see p62 level is increased in starved samples.

\- Response to this comment:

We appreciate the reviewer's comment. In fact, the experimental data shown in Fig 4 are obtained under mutant SOD1-induced neurodegenerative conditions in vivo (as an ALS model), not under starved conditions. Although overexpression of SOD1 mutant (H46R) in mice can activate the autophagy, neurodegenerative stress overwhelms the capacity of protein degradation processes (not only autophagy but also the ubiquitin proteasome system), thereby progressively accumulating SQSTM1/p62, particularly, in the spinal cord (Hadano et al, PLoS ONE 2010; Hadano et al. Hum Mol Genet 2016; Mitsui et al Mol Brain 2018). As the reviewer pointed out, we have indeed observed a transient decrease of the SQSTM1/p62 levels in MEFs (in vitro) under starved conditions (see Fig 6A). However, in this study, we only analyzed the levels of LC3 (Figs 2&3), but not those of SQSTM1/p62, under starved conditions in vivo.

By submitting the manuscript to PLoS ONE, we understand that "the work described has not been submitted for publication, in whole or in part, elsewhere and all the authors listed have approved the manuscript that is enclosed". We understand that "should the submitted material be accepted for publication in PLoS ONE, we will automatically transfer the copyright to the publisher". Further, the authors have declared that no competing interests exist.

We hope that all the changes we made meet your acceptance of the manuscript for publication in PLoS ONE. Thank you for your generous consideration. We are looking forward to hearing from you soon.

Sincerely yours,

Shinji Hadano, Ph.D.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

Professor of Department of Molecular Life Sciences

Tokai University School of Medicine

143 Shimokasuya, Isehara, Kanagawa 259-1193, JAPAN

TEL: +81-463-93-1121 (ext. 2567)

FAX: +81-463-93-3965

E-mail: <shinji@is.icc.u-tokai.ac.jp>

10.1371/journal.pone.0234180.r007
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21 May 2020

Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B

PONE-D-19-24727R3

Dear Dr. Hadano,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Vladimir Trajkovic

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

10.1371/journal.pone.0234180.r008
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This is an open access article distributed under the terms of the

Creative Commons Attribution License
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26 May 2020

PONE-D-19-24727R3

Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B

Dear Dr. Hadano:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.
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